V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20031607 | 20013487 | null | null | Adjuvant (A) | null | 2014-11-02 | FEC + DOCETAXEL | null | null | 20111306 | FEC + DOCETAXEL |
| 20031608 | 20013488 | 1.83 | 66.4 | Adjuvant (A) | 2016-07-26 | 2016-08-25 | FEC + DOCETAXEL | N | N | 20111307 | FEC + DOCETAXEL |
| 20031610 | 20013489 | null | 93.5 | Adjuvant (A) | 2016-08-17 | 2016-09-10 | FEC 100 + DOCETAXEL | N | N | 20111310 | FEC + DOCETAXEL |
| 20031611 | 20013490 | null | 72.3 | null | 2013-09-20 | 2013-09-27 | FEC + DOCETAXEL | N | N | 20111319 | FEC + DOCETAXEL |
| 20031612 | 20013490 | 1.79 | 83.3 | Curative (C) | null | 2014-10-12 | FEC 100 + DOCETAXEL | N | N | 20111319 | FEC + DOCETAXEL |
| 20031613 | 20013491 | 1.66 | null | null | 2015-04-25 | 2015-05-05 | FEC + DOCETAXEL | 2 | N | 20111322 | FEC + DOCETAXEL |
| 20031614 | 20013491 | 1.48 | 65 | Adjuvant (A) | 2013-11-04 | 2013-11-18 | FEC + DOCETAXEL | N | N | 20111322 | FEC + DOCETAXEL |
| 20031615 | 20013492 | null | null | Adjuvant (A) | 2013-04-09 | 2013-04-16 | FEC + DOCETAXEL | N | N | 20111327 | FEC + DOCETAXEL |
| 20031616 | 20013492 | 1.57 | 105 | Adjuvant (A) | 2014-06-18 | 2014-06-27 | FEC 100 + DOCETAXEL | 02 | N | 20111327 | FEC + DOCETAXEL |
| 20031617 | 20013493 | null | 67.8 | Adjuvant (A) | 2017-10-25 | 2017-11-05 | FEC 100 + DOCETAXEL | N | N | 20111329 | FEC + DOCETAXEL |
| 20031618 | 20013493 | 1.57 | 54.1 | Neo-adjuvant (N) | 2015-06-22 | 2015-07-16 | FEC + DOCETAXEL | 2 | N | 20111329 | FEC + DOCETAXEL |
| 20031619 | 20013494 | 1.7 | 68 | Adjuvant (A) | null | 2014-08-23 | FEC 100 + DOCETAXEL | N | N | 20111339 | FEC + DOCETAXEL |
| 20031620 | 20073227 | 1.68 | 76.4 | Adjuvant (A) | 2015-01-27 | 2015-02-23 | FEC 100 + DOCETAXEL | N | N | 20111345 | FEC + DOCETAXEL |
| 20031621 | 20013495 | 1.57 | 88 | Adjuvant (A) | null | 2013-04-02 | FEC 100 + DOCETAXEL | N | N | 20111346 | FEC + DOCETAXEL |
| 20031622 | 20013496 | 1.62 | null | Adjuvant (A) | 2015-09-30 | 2015-10-18 | FEC + DOCETAXEL | null | N | 20111349 | FEC + DOCETAXEL |
| 20031623 | 20013496 | null | 66.4 | Adjuvant (A) | 2015-11-21 | 2015-12-03 | FEC + DOCETAXEL | N | N | 20111349 | FEC + DOCETAXEL |
| 20031624 | 20013497 | 1.71 | 56 | Adjuvant (A) | 2017-12-04 | 2017-12-07 | FEC + DOCETAXEL | 02 | null | 20111365 | FEC + DOCETAXEL |
| 20031625 | 20013497 | null | 80.9 | Neo-adjuvant (N) | 2014-06-05 | 2014-06-19 | FEC 100 + DOCETAXEL | N | N | 20111365 | FEC + DOCETAXEL |
| 20031626 | 20013498 | 1.61 | 54 | Neo-adjuvant (N) | 2018-01-06 | 2018-01-06 | FEC + DOCETAXEL | 02 | N | 20111368 | FEC + DOCETAXEL |
| 20031627 | 20013498 | 1.54 | 78.1 | Adjuvant (A) | 2014-07-16 | 2014-07-22 | FEC + DOCETAXEL | 02 | N | 20111368 | FEC + DOCETAXEL |
| 20031628 | 20013498 | 1.72 | 86 | Adjuvant (A) | 2017-04-28 | 2017-05-05 | FEC + DOCETAXEL | 02 | Y | 20111368 | FEC + DOCETAXEL |
| 20031629 | 20013498 | 0 | 80.9 | Neo-adjuvant (N) | 2014-03-23 | 2014-03-28 | FEC + DOCETAXEL | 2 | N | 20111368 | FEC + DOCETAXEL |
| 20031630 | 20013499 | 1.74 | null | Adjuvant (A) | 2016-01-09 | 2016-01-28 | FEC 100 + DOCETAXEL | N | Y | 20111385 | FEC + DOCETAXEL |
| 20031631 | 20013499 | 1.58 | 113 | Neo-adjuvant (N) | 2017-04-27 | 2017-04-27 | FEC 100 + DOCETAXEL | 2 | N | 20111385 | FEC + DOCETAXEL |
| 20031632 | 20013500 | 1.7 | 93 | Neo-adjuvant (N) | 2018-03-23 | 2018-03-31 | FEC + DOCETAXEL | 02 | Y | 20111397 | FEC + DOCETAXEL |
| 20031633 | 20013500 | 1.69 | 79.5 | Adjuvant (A) | 2016-05-26 | 2016-05-27 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20111397 | FEC + DOCETAXEL |
| 20031634 | 20013500 | 1.58 | 67 | Adjuvant (A) | 2013-10-24 | 2013-10-24 | FEC + DOCETAXEL | 02 | N | 20111397 | FEC + DOCETAXEL |
| 20031635 | 20013500 | null | null | Adjuvant (A) | 2013-11-26 | 2013-12-26 | FEC 100 + DOCETAXEL | N | N | 20111397 | FEC + DOCETAXEL |
| 20031636 | 20013501 | 1.7 | 111.4 | Neo-adjuvant (N) | 2018-02-13 | 2018-02-15 | FEC + DOCETAXEL | 2 | N | 20111416 | FEC + DOCETAXEL |
| 20031637 | 20013501 | 1.7 | null | Adjuvant (A) | null | 2013-09-11 | FEC 100 + DOCETAXEL | null | null | 20111416 | FEC + DOCETAXEL |
| 20031638 | 20013502 | 1.47 | 64.6 | Adjuvant (A) | 2014-09-08 | 2014-09-14 | FEC 100 + DOCETAXEL | 02 | N | 20111422 | FEC + DOCETAXEL |
| 20031639 | 20013502 | 1.6 | 74.8 | Adjuvant (A) | null | 2015-10-15 | FEC 100 + DOCETAXEL | N | N | 20111422 | FEC + DOCETAXEL |
| 20031640 | 20013503 | 1.64 | 78.8 | Adjuvant (A) | 2016-09-13 | 2016-10-06 | FEC + DOCETAXEL | N | N | 20111430 | FEC + DOCETAXEL |
| 20031641 | 20013504 | 1.7 | 71 | Adjuvant (A) | 2016-01-10 | 2016-01-12 | FEC 100 + DOCETAXEL | 2 | null | 20111432 | FEC + DOCETAXEL |
| 20031642 | 20013504 | null | null | Adjuvant (A) | 2018-01-28 | 2018-02-12 | FEC 100 + DOCETAXEL | null | null | 20111432 | FEC + DOCETAXEL |
| 20031643 | 20013504 | 1.66 | 104.9 | Adjuvant (A) | 2014-11-12 | 2014-11-13 | FEC 100 + DOCETAXEL | 02 | N | 20111432 | FEC + DOCETAXEL |
| 20031644 | 20013505 | 1.54 | 105.4 | Adjuvant (A) | 2016-09-29 | 2016-09-30 | FEC + DOCETAXEL | 02 | null | 20111451 | FEC + DOCETAXEL |
| 20031645 | 20013505 | 1.7 | 90.2 | Adjuvant (A) | 2018-02-17 | 2018-02-18 | FEC 100 + DOCETAXEL | 2 | N | 20111451 | FEC + DOCETAXEL |
| 20031646 | 20013506 | 1.69 | 86 | Adjuvant (A) | 2015-02-11 | 2015-02-15 | FEC + DOCETAXEL | 02 | N | 20111457 | FEC + DOCETAXEL |
| 20031647 | 20013506 | 1.64 | 60.8 | Not known (9) | 2017-05-24 | 2017-06-15 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20111457 | FEC + DOCETAXEL |
| 20031648 | 20013506 | 1.62 | 59.8 | Adjuvant (A) | 2013-06-14 | 2013-06-27 | FEC 100 + DOCETAXEL | 02 | null | 20111457 | FEC + DOCETAXEL |
| 20031649 | 20013506 | 1.8 | 48 | Adjuvant (A) | 2018-05-13 | 2018-05-13 | FEC + DOCETAXEL | 02 | N | 20111457 | FEC + DOCETAXEL |
| 20031650 | 20013507 | 1.68 | 65.6 | Curative (C) | 2017-08-29 | 2017-08-30 | FEC 100 + DOCETAXEL | 02 | N | 20111467 | FEC + DOCETAXEL |
| 20031651 | 20013507 | 1.65 | 81.5 | Palliative (P) | 2014-05-22 | 2014-05-25 | FEC + DOCETAXEL | 2 | N | 20111467 | FEC + DOCETAXEL |
| 20031652 | 20013508 | null | 109.05 | Adjuvant (A) | null | 2016-08-02 | FEC + DOCETAXEL | 02 | N | 20111474 | FEC + DOCETAXEL |
| 20031653 | 20013508 | 1.69 | null | Palliative (P) | 2013-02-07 | 2013-02-22 | FEC + DOCETAXEL | N | N | 20111474 | FEC + DOCETAXEL |
| 20031654 | 20013509 | 1.63 | 87.7 | Adjuvant (A) | 2013-07-08 | 2013-07-27 | FEC + DOCETAXEL | N | N | 20111491 | FEC + DOCETAXEL |
| 20031655 | 20073240 | null | null | Adjuvant (A) | 2015-10-06 | 2015-10-08 | FEC 100 + DOCETAXEL | N | N | 20111494 | FEC + DOCETAXEL |
| 20031656 | 20073240 | 1.52 | 73 | Adjuvant (A) | 2017-06-15 | 2017-06-30 | FEC + DOCETAXEL | null | N | 20111494 | FEC + DOCETAXEL |
| 20031657 | 20073240 | null | null | Adjuvant (A) | null | 2013-12-10 | FEC + DOCETAXEL | null | null | 20111494 | FEC + DOCETAXEL |